MSD
Pfizer head to be ABPI president
December 4, 2013Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna
The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …
Merck to close Irish plant with loss of 570 jobs
December 2, 2013Manufacturing and Production, Sales and Marketing Ireland, MSD, Merck, job cuts, swords
Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …
MSD’s sugammadex knocked back by FDA – again
September 25, 2013Research and Development, Sales and Marketing FDA, MSD, Merck, Sugammedex
Merck told to make $1 billion in cuts
August 22, 2013Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex
MSD cleared by PMCPA
July 23, 2013Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code
Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …
MSD takes Januvia rap
July 9, 2013Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA
Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …
Aspen buys Merck facility and products in $1 billion deal
July 1, 2013Manufacturing and Production MSD, Merck, Oss, aspen
Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …
Merck to close Irish manufacturing unit
March 11, 2013Manufacturing and Production MSD, Merck
Merck & Co has said that a manufacturing unit in Rathdrum, Ireland will close by the end of 2015 with …
Two hepatitis C drugs win Prix Galien
September 28, 2012Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien
Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …
MSD joins forces with PatientsLikeMe for psoriasis
August 14, 2012Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis
MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …
UK drug pricing: ABPI wants evolution, not revolution
June 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing
As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …
Two new hep C pills recommended by NICE
April 25, 2012Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C
NICE has given its final recommendation for two new hepatitis C pills in an expedited review. Janssen’s Incivo (telaprevir) and …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
Merck appoints new chief ethics and compliance officer
March 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck
Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
Merck facility reborn as science park
January 11, 2012Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland
A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
